ShopVision | $4,100,000 | (Sep 19, 2025)
Hydrostor | $55,000,000 | (Sep 19, 2025)
Samara(US) | $34,000,000 | (Sep 19, 2025)
Certified by Founder
Lodge
Koneksa
start up
United States
- New York
- 08/02/2022
- Series C
- $45,000,000
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
- Industry Pharmaceutical Manufacturing
- Website http://www.koneksahealth.com/
- LinkedIn https://www.linkedin.com/company/koneksa-health/
Related People
Chris BenkoFounder
United States -
New York, New York
NA
LinkedIn
https://www.linkedin.com/in/cbenko/
Sevaro | $39,000,000 | (Sep 19, 2025)
Centari | $14,000,000 | (Sep 19, 2025)
Terra Oleo | $3,100,000 | (Sep 19, 2025)
Phia | $8,000,000 | (Sep 19, 2025)
Vibranium Labs | $4,600,000 | (Sep 19, 2025)
Invisible Technologies | $100,000,000 | (Sep 18, 2025)
Stablecore | $20,000,000 | (Sep 18, 2025)
Markup AI | $27,500,000 | (Sep 18, 2025)
Moby | $5,000,000 | (Sep 18, 2025)